NCT00555347View on ClinicalTrials.gov

Use of Armodafinil for Fatigue in Sarcoidosis

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2011

Conditions

SarcoidosisFatigueSleepiness

Interventions

DRUG

Armodafinil

Dosage 150-250 mg

DRUG

Placebo

Placebo

Trial Locations (1)

45267

University of Cincinnati, Cincinnati

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Cephalon

INDUSTRY

lead

University of Cincinnati

OTHER

NCT00555347 - Use of Armodafinil for Fatigue in Sarcoidosis | Biotech Hunter | Biotech Hunter